BRPI0512025A - usos antiparasìticos de complexos de ácido borìnico - Google Patents

usos antiparasìticos de complexos de ácido borìnico

Info

Publication number
BRPI0512025A
BRPI0512025A BRPI0512025-0A BRPI0512025A BRPI0512025A BR PI0512025 A BRPI0512025 A BR PI0512025A BR PI0512025 A BRPI0512025 A BR PI0512025A BR PI0512025 A BRPI0512025 A BR PI0512025A
Authority
BR
Brazil
Prior art keywords
acid complexes
boronic acid
antiparasitic
antiparasitic uses
borinic acid
Prior art date
Application number
BRPI0512025-0A
Other languages
English (en)
Inventor
Carolyn Bellinger-Kawahara
Kirk R Maples
Original Assignee
Anacor Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anacor Pharmaceuticals Inc filed Critical Anacor Pharmaceuticals Inc
Publication of BRPI0512025A publication Critical patent/BRPI0512025A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/69—Boron compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/08—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis for Pneumocystis carinii
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

USOS ANTIPARASìTICOS DE COMPLEXOS DE áCIDO BORìNICO São descritas composições e métodos de uso de complexos de ácido borínico, especialmente hidroxiquinolina, imidazol e derivados de ácido picolínico, como agentes antiparasíticos bem como agentes terapêuticas para o tratamento de doenças causadas por parasitas.
BRPI0512025-0A 2004-06-14 2005-06-14 usos antiparasìticos de complexos de ácido borìnico BRPI0512025A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57947604P 2004-06-14 2004-06-14
PCT/US2005/021219 WO2005123095A1 (en) 2004-06-14 2005-06-14 Anti-parasitic uses of borinic acid complexes

Publications (1)

Publication Number Publication Date
BRPI0512025A true BRPI0512025A (pt) 2008-02-06

Family

ID=34979015

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0512025-0A BRPI0512025A (pt) 2004-06-14 2005-06-14 usos antiparasìticos de complexos de ácido borìnico

Country Status (9)

Country Link
US (1) US20060014723A1 (pt)
EP (1) EP1771182A1 (pt)
JP (1) JP2008502702A (pt)
AR (1) AR049916A1 (pt)
BR (1) BRPI0512025A (pt)
CA (1) CA2570534A1 (pt)
MX (1) MXPA06014414A (pt)
TW (1) TW200610530A (pt)
WO (1) WO2005123095A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2008015918A (es) * 2006-06-12 2009-01-14 Anacor Pharmaceuticals Inc Compuestos para el tratamiento de enfermedad periodontal.
WO2010018837A2 (ja) * 2008-08-11 2010-02-18 独立行政法人科学技術振興機構 蛋白質架橋阻害剤
EP2337786B1 (en) * 2008-10-02 2013-08-14 Basf Se Complex salts
KR101756785B1 (ko) * 2015-03-10 2017-07-12 한국화학연구원 4배위 유기 붕소 화합물의 제조방법
CN111995634B (zh) * 2020-08-28 2022-08-05 深圳大学 一种四配位有机硼化合物、荧光探针及其制备方法与应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5348947A (en) * 1993-05-07 1994-09-20 American Cyanamid Company Diarylboron ester and thioester fungicidal agents
US5348948A (en) * 1993-05-07 1994-09-20 American Cyanamid Company 2,2-diaryl-1-(oxa and thia)-2a-azonia-2-borataacenaphthene fungicidal
US5574017A (en) * 1994-07-05 1996-11-12 Gutheil; William G. Antibacterial agents
EP1155698A4 (en) * 1999-01-29 2003-01-15 Nitto Kasei Co Ltd ORGANOBORAL COMPOUNDS HAVING COCCIDIOSTAT ACTIVITY
DE10110051C2 (de) * 2001-03-02 2003-07-03 Clariant Gmbh Verfahren zur Herstellung von Boron- und Borinsäuren
JP2006511613A (ja) * 2002-12-18 2006-04-06 アナコア ファーマシューティカルズ インコーポレイテッド ボロン酸複合体を含む抗生物質および使用法
US7390806B2 (en) * 2002-12-18 2008-06-24 Anacor Pharmaceuticals, Inc. Antibiotics containing borinic acid complexes and methods of use

Also Published As

Publication number Publication date
MXPA06014414A (es) 2007-03-08
EP1771182A1 (en) 2007-04-11
WO2005123095A1 (en) 2005-12-29
JP2008502702A (ja) 2008-01-31
US20060014723A1 (en) 2006-01-19
AR049916A1 (es) 2006-09-13
TW200610530A (en) 2006-04-01
CA2570534A1 (en) 2005-12-29

Similar Documents

Publication Publication Date Title
BRPI0512049A (pt) usos antivirais de complexos de ácido borìnico
BRPI0512108A (pt) antibióticos contendo complexos de ácido borìnico e métodos de uso
CR20110230A (es) Inhibidores de las enzimas de proteina cinasa activadas por mitogeno p38
WO2004108139A3 (en) Use of fused heterocyclic compounds as scce inhibitors for the treatment of skin conditions or cancer
ECSP11010949A (es) Inhibidores de las enzimas de proteína cinasa activadas por mitógeno p38
HK1096392A1 (en) Substituted heterocycles
MX2011010673A (es) Formulaciones de nanoparticulas y usos de las mismas.
BRPI0512054A (pt) compostos contendo boro e métodos de utilização
BR0317564A (pt) Compostos, composições e métodos para tratar doenças causadas por bactérias ou fungos
EA200800555A1 (ru) Производные ксантина в качестве селективных агонистов hm74a
BRPI0513513A (pt) composto ou um sal farmaceuticamente aceitável do mesmo, processo para preparar o mesmo, composição farmacêutica, uso de um composto ou um sal farmaceuticamente aceitável do mesmo, e, métodos para produzir um efeito inibitório de eg5 e um efeito anticáncer em um animal de sangue quente, e para tratar carcinomas em um animal de sangue quente
CL2008001745A1 (es) Compuestos derivados de imidazo[1,2-a]pirazina; composición farmacéutica; y uso de los compuestos como inhibidores de la proteína quinasa en el tratamiento del cáncer.
NO20070782L (no) Tetrapeptidanaloger.
DE60319406D1 (de) Meso-substituierte porphyrine
BR0206161A (pt) 2-fenil benzimidazóis e imidazo-[4,5]-piridinas como inibidores de cds1/chk2 e adjuvantes para quimioterapia ou terapia por radiação no tratamento de câncer
MX338088B (es) Imidazoquinolinas y derivados de pirimidina como moduladores potentes de los procesos angiogenicos impulsados por el factor de crecimiento endotelial vascular (vegf).
UY29046A1 (es) Derivados de n-(1h-indolil)-1h-indol-2-carboxamidas, su preparación y su uso en terapia
TW200510392A (en) Chemical compounds
BRPI0512025A (pt) usos antiparasìticos de complexos de ácido borìnico
CL2008000495A1 (es) Compuestos derivados de tetrahidro-pirazolo[4,3-c]piridina; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como alergias, inflamacion, dolor, cancer, entreotras.
TW200505452A (en) Chemical compounds
NO20074780L (no) Heterocyklylamidsubstituerte imidazoler
ATE531698T1 (de) 4-aminocarbonylamino-substitutierte imidazolverbindungen mit antiviraler wirkung
DK1904511T3 (da) Homogemcitabin
ATE553088T1 (de) Substituierte chinolone ii

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012.